Suthanthiran et al. reported that serum TGF-β1 levels had a positive association with several risk factors for CKD progression in African-American patients, and suggested that serum TGF-β1 can serve as a reliable biomarker for CKD progression [27]. The gene discussed is TGFB1; the disease is chronic kidney disease.